Literature DB >> 1312135

Acetylcholine synthesis and release is enhanced by dibutyryl cyclic AMP in a neuronal cell line derived from mouse septum.

J K Blusztajn1, A Venturini, D A Jackson, H J Lee, B H Wainer.   

Abstract

Cholinergic properties of the SN56.B5.G4 cell line derived from the fusion of neurons of the mouse postnatal day 21 septum and the murine neuroblastoma cell line N18TG2 were investigated and correlated with morphological differentiation. In basal serum-containing growth medium, few cells developed neurites. Neurite extension occurred in cells grown for 2 d with forskolin or dibutyryl cAMP (dbcAMP) but not with butyrate. In cells treated with these compounds, the activity of ChAT and ACh content were two- to threefold higher relative to controls. The cells synthesized ACh from choline taken up by the sodium-dependent high-affinity transport. Forskolin-, dbcAMP-, and butyrate-treated cells (but not the controls) were capable of spontaneous and depolarization-evoked ACh release. The results indicate that the morphological and the neurochemical aspects of SN56.B5.G4 cell differentiation are independently regulated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312135      PMCID: PMC6576034     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  14 in total

1.  Developmental expression of muscarinic acetylcholine receptors in chick retina: selective induction of M2 muscarinic receptor expression in ovo by a factor secreted by muller glial cells.

Authors:  K E Belmonte; L A McKinnon; N M Nathanson
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Identifying monoaminergic, GABAergic, and cholinergic characteristics in immortalized neuronal cell lines.

Authors:  F Gallyas; J Satoh; A M Takeuchi; Y Konishi; T Kunishita; T Tabira
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

3.  Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs.

Authors:  A Szutowicz; H Bielarczyk; S Gul; A Ronowska; T Pawełczyk; A Jankowska-Kulawy
Journal:  Metab Brain Dis       Date:  2006-05-25       Impact factor: 3.584

4.  Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor.

Authors:  B Berse; I Lopez-Coviella; J K Blusztajn
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 5.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

Review 6.  Acetylcholine release and the cholinergic genomic locus.

Authors:  M Israël; Y Dunant
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

7.  Short-term nutritional folate deficiency in rats has a greater effect on choline and acetylcholine metabolism in the peripheral nervous system than in the brain, and this effect escalates with age.

Authors:  Natalia A Crivello; Jan K Blusztajn; James A Joseph; Barbara Shukitt-Hale; Donald E Smith
Journal:  Nutr Res       Date:  2010-10       Impact factor: 3.315

8.  Differential regulation of the high affinity choline transporter and the cholinergic locus by cAMP signaling pathways.

Authors:  Martina Brock; Ann-Christin Nickel; Beata Madziar; Jan Krzysztof Blusztajn; Brygida Berse
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

9.  Acetylcholine and tachykinins involvement in the caffeine-induced biphasic change in intracellular Ca2+ in bovine airway smooth muscle.

Authors:  Luis M Montaño; Verónica Carbajal; José L Arreola; Carlos Barajas-López; Edgar Flores-Soto; Mario H Vargas
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

10.  Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res.

Authors:  Gerald S Baron; Ana C Magalhães; Marco A M Prado; Byron Caughey
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.